| Primary |
| Atrial Fibrillation |
25.9% |
| Hypertension |
14.8% |
| Angina Pectoris |
7.4% |
| Arrhythmia |
3.7% |
| Arrhythmia Prophylaxis |
3.7% |
| Asthma |
3.7% |
| Benign Prostatic Hyperplasia |
3.7% |
| Bronchitis |
3.7% |
| Depression |
3.7% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Heart Rate Irregular |
3.7% |
| Hyperlipidaemia |
3.7% |
| Hyperphosphataemia |
3.7% |
| Pneumonia Bacterial |
3.7% |
| Prostate Cancer |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Wolff-parkinson-white Syndrome |
3.7% |
|
| Hypoglycaemia |
14.3% |
| Blood Creatinine Increased |
7.1% |
| Cardiac Arrest |
7.1% |
| Drug Interaction |
7.1% |
| Hypoglycaemic Coma |
7.1% |
| Product Substitution Issue |
7.1% |
| Syncope |
7.1% |
| Tachycardia |
7.1% |
| Torsade De Pointes |
7.1% |
| Viral Infection |
7.1% |
| Vision Blurred |
7.1% |
| Weight Increased |
7.1% |
| Xanthopsia |
7.1% |
|
| Secondary |
| Atrial Fibrillation |
15.2% |
| Drug Use For Unknown Indication |
14.2% |
| Arrhythmia |
9.3% |
| Product Used For Unknown Indication |
9.3% |
| Angina Pectoris |
8.3% |
| Diabetes Mellitus |
7.8% |
| Hypertension |
7.4% |
| Pneumonia |
3.9% |
| Myasthenia Gravis |
2.9% |
| Arteriosclerosis Obliterans |
2.5% |
| Dyslipidaemia |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Atrial Tachycardia |
2.0% |
| Cardiac Failure |
2.0% |
| Dementia Alzheimer's Type |
2.0% |
| Gastritis |
2.0% |
| Insomnia |
2.0% |
| Asthma |
1.5% |
| Bronchitis Chronic |
1.5% |
| Constipation |
1.5% |
|
| Ventricular Tachycardia |
18.6% |
| Torsade De Pointes |
15.3% |
| Hypoglycaemia |
10.2% |
| Drug Interaction |
5.1% |
| Hepatic Function Abnormal |
5.1% |
| Long Qt Syndrome |
5.1% |
| Syncope |
5.1% |
| Completed Suicide |
3.4% |
| Overdose |
3.4% |
| Shock |
3.4% |
| Suicide Attempt |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Vagus Nerve Disorder |
3.4% |
| Ventricular Extrasystoles |
3.4% |
| Ventricular Fibrillation |
3.4% |
| C-reactive Protein Increased |
1.7% |
| Cardiac Disorder |
1.7% |
| Death |
1.7% |
| Drug-induced Liver Injury |
1.7% |
| Fall |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
11.7% |
| Hypertension |
10.2% |
| Atrial Fibrillation |
7.5% |
| Arrhythmia |
5.8% |
| Rheumatoid Arthritis |
4.9% |
| Insomnia |
4.6% |
| Prophylaxis |
4.0% |
| Osteoporosis |
3.1% |
| Pain |
2.4% |
| Hyperlipidaemia |
2.2% |
| Schizophrenia |
2.2% |
| Asthma |
2.0% |
| Diabetes Mellitus |
2.0% |
| Anaesthesia |
1.8% |
| Constipation |
1.8% |
| Arteriosclerosis Obliterans |
1.5% |
| Bronchiolitis |
1.5% |
| Cardiac Failure Chronic |
1.5% |
| Hepatitis C |
1.5% |
|
| Metastatic Neoplasm |
9.9% |
| Ventricular Tachycardia |
8.5% |
| Palpitations |
5.6% |
| Rhabdomyolysis |
5.6% |
| Vomiting |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Withdrawal Syndrome |
5.6% |
| Atrial Fibrillation |
4.2% |
| Interstitial Lung Disease |
4.2% |
| Linear Iga Disease |
4.2% |
| Osteomyelitis |
4.2% |
| Pancreatitis |
4.2% |
| Pyrexia |
4.2% |
| Rash Generalised |
4.2% |
| Renal Disorder |
4.2% |
| Renal Impairment |
4.2% |
| Renal Tubular Necrosis |
4.2% |
| Sepsis |
4.2% |
| Urinary Tract Infection |
4.2% |
| Aneurysm |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
24.6% |
| Atrial Fibrillation |
18.9% |
| Dyslipidaemia |
13.7% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Gastric Haemorrhage |
3.4% |
| Gastritis Erosive |
3.4% |
| Helicobacter Infection |
3.4% |
| Hyperthyroidism |
3.4% |
| Nasopharyngitis |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Arrhythmia |
2.9% |
| Asthma |
2.3% |
| Hypertension |
2.3% |
| Pneumonia |
2.3% |
| Pneumonia Bacterial |
2.3% |
| Bronchitis |
1.7% |
| Angina Pectoris |
1.1% |
| Bronchitis Chronic |
1.1% |
| Constipation |
1.1% |
| Depression |
1.1% |
|
| Torsade De Pointes |
32.0% |
| Drug Interaction |
20.0% |
| Hypoglycaemic Coma |
12.0% |
| Hypoglycaemia |
8.0% |
| Reflux Oesophagitis |
8.0% |
| Electrocardiogram Qt Prolonged |
4.0% |
| Sinus Bradycardia |
4.0% |
| Subileus |
4.0% |
| Thyroxine Decreased |
4.0% |
| Ventricular Tachycardia |
4.0% |
|
